Form 4: Moderna's Chief Legal Officer Shannon Thyme Klinger Reports Stock Transactions
SEC Form 4 Filing
Shannon Thyme Klinger, Moderna's Chief Legal Officer, reported the acquisition and disposal of company stock, including transactions to cover tax obligations related to vesting restricted stock units.
Summary
- On August 28, 2024, Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc., acquired 329 shares of common stock through the vesting of restricted stock units (RSUs).
- Also on August 28, 2024, Klinger disposed of 329 shares related to the vesting of RSUs.
- On August 29, 2024, Klinger disposed of 162 shares of common stock at a price of $78.026 per share to cover tax withholding obligations.
- Following these transactions, Klinger directly owns 17,447 shares of Moderna common stock.
- The sales to cover tax obligations are mandated by Moderna's equity incentive plans and do not represent discretionary trades by Klinger.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency to the market regarding the buying and selling activities of company executives and directors.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 08/28/2024 | Acquisition of 329 shares through RSU vesting and disposal of 329 shares. |
| 08/29/2024 | Sale of 162 shares at $78.026 to cover tax obligations. |
| 08/30/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.